Birgit C Schultes

EVP, Chief Scientific Officer, Intellia Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.1M

Companies

Latest trade

Jan 5, 2026

Companies

Intellia Therapeutics, Inc.EVP, Chief Scientific Officer −$0.1M

Trades

NTLA Sold 8,508 shares at $9.21 $0.1M Jan 5

NTLA Sold 31 shares at $17.38 $0.0M Oct 1

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.